NewAmsterdam Pharma Company
NAMS
#4361
Rank
โ‚ฌ1.58 B
Marketcap
14,42ย โ‚ฌ
Share price
-12.17%
Change (1 day)
-27.00%
Change (1 year)

Revenue for NewAmsterdam Pharma Company (NAMS)

Revenue in 2024 (TTM): โ‚ฌ41.75 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM ) is โ‚ฌ41.56 Million. an increase over the revenue in the year 2023 that were of โ‚ฌ12.74 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NewAmsterdam Pharma Company from 2023 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ43.78 M243.52%
2023 โ‚ฌ12.74 M